Ticarcillin Sodium

Ticarcillin Sodium may be available in the countries listed below.

Ingredient matches for Ticarcillin Sodium

Ticarcillin

Ticarcillin Sodium (BANM, JAN) is known as Ticarcillin in the US.

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
JAN	Japanese Accepted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Patcon

Patcon may be available in the countries listed below.

Ingredient matches for Patcon

Pentoxyverine

Pentoxyverine citrate (a derivative of Pentoxyverine) is reported as an ingredient of Patcon in the following countries:

• Japan

International Drug Name Search

Insuman N

Insuman N may be available in the countries listed below.

Ingredient matches for Insuman N

Insulin, Isophane

Insulin, Isophane human (a derivative of Insulin, Isophane) is reported as an ingredient of Insuman N in the following countries:

• Argentina


• Colombia


• Costa Rica


• Dominican Republic


• Ecuador


• El Salvador


• Guatemala


• Honduras


• Nicaragua


• Panama

International Drug Name Search

Iramox

Iramox may be available in the countries listed below.

Ingredient matches for Iramox

Amoxicillin

Amoxicillin is reported as an ingredient of Iramox in the following countries:

• Oman

International Drug Name Search

Apidra

See also: Generic Apidra Solostar

Apidra is a brand name of insulin glulisine, approved by the FDA in the following formulation(s):

APIDRA (insulin glulisine recombinant - injectable; iv (infusion)-sc)

• 
  Manufacturer: SANOFI AVENTIS US
  
  Approval date: April 16, 2004
  
  Strength(s): 1000 UNITS/10ML (100 UNITS/ML) ^[RLD]


• 
  Manufacturer: SANOFI AVENTIS US
  
  Approval date: December 20, 2005
  
  Strength(s): 300 UNITS/3ML (100 UNITS/ML) ^[RLD]

Has a generic version of Apidra been approved?

No. There is currently no therapeutically equivalent version of Apidra available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Apidra. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Insulin derivatives having a rapid onset of action
  Patent 6,221,633
  Issued: April 24, 2001
  Inventor(s): Ertl; Johann & Habermann; Paul & Geisen; Karl & Seipke; Gerhard
  Assignee(s): Aventis Pharma Deutschland GmbH
  The present invention relates to insulin derivatives which in comparison to human insulin, have an accelerated onset of action, to a process for their preparation and to their use, in particular in pharmaceutical preparations for the treatment of diabetes mellitus. In particular, the present invention relates to insulin derivatives or physiologically tolerable salts thereof in which asparagine (Asn) in position B3 of the B chain is replaced by a naturally occurring basic amino acid residue and at least one amino acid residue in the positions B27, B28 or B29 of the B chain is replaced by another naturally occurring amino acid residue, it optionally being possible for asparagine (Asn) in position 21 of the A chain to be replaced by Asp, Gly, Ser, Thr or Ala and for phenylalanine (Phe) in position B1 of the B chain and the amino acid residue in position B30 of the B chain to be absent.
  
  Patent expiration dates:
  
  
  • June 18, 2018
    
    ✓ 
    Patent use: METHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  Zinc-free and low-zinc insulin preparations having improved stability
  Patent 6,960,561
  Issued: November 1, 2005
  Inventor(s): Boderke; Peter
  Assignee(s): Aventis Pharma Deutschland GmbH
  The invention relates to a formulation comprising a polypeptide selected from at least one of insulin, an insulin metabolite, an insulin analog, and an insulin derivative; at least one surfactant; optionally at least one preservative; and optionally at least one of an isotonicizing agent, a buffer or an excipient, wherein the formulation is free from or low in zinc. The invention also relates to the production of such insulin preparations and their use as pharmaceutical formulations.
  
  Patent expiration dates:
  
  
  • January 25, 2023
    
    ✓ 
    Patent use: METHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS
    ✓ 
    Drug product
  
  



• 
  Zinc-free and low-zinc insulin preparations having improved stability
  Patent 7,452,860
  Issued: November 18, 2008
  Inventor(s): Boderke; Peter
  Assignee(s): Sanofi-Aventis Deutschland GmbH
  The invention relates to a formulation comprising a polypeptide selected from at least one of insulin, an insulin metabolite, an insulin analog, and an insulin derivative; at least one surfactant; optionally at least one preservative; and optionally at least one of an isotonicizing agent, a buffer or an excipient, wherein the formulation is free from or low in zinc. The invention also relates to the production of such insulin preparations and their use as pharmaceutical formulations.
  
  Patent expiration dates:
  
  
  • March 22, 2022
    
    ✓ 
    Drug product
  
  



• 
  Zinc-free and low-zinc insulin preparations having improved stability
  Patent 7,696,162
  Issued: April 13, 2010
  Inventor(s): Boderke; Peter
  Assignee(s): Sanofi-Aventis Deutschland GmbH
  The invention relates to a formulation comprising a polypeptide selected from at least one of insulin, an insulin metabolite, an insulin analog, and an insulin derivative; at least one surfactant; optionally at least one preservative; and optionally at least one of an isotonicizing agent, a buffer or an excipient, wherein the formulation is free from or low in zinc. The invention also relates to the production of such insulin preparations and their use as pharmaceutical formulations.
  
  Patent expiration dates:
  
  
  • March 22, 2022
    
    ✓ 
    Patent use: METHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • October 24, 2011 - NEW PATIENT POPULATION
  
  

See also...

• Apidra Consumer Information (Drugs.com)
• Apidra Cartridges Consumer Information (Wolters Kluwer)
• Apidra Vials Consumer Information (Wolters Kluwer)
• Apidra Consumer Information (Cerner Multum)
• Apidra OptiClik Cartridge Consumer Information (Cerner Multum)
• Apidra Advanced Consumer Information (Micromedex)
• Apidra AHFS DI Monographs (ASHP)
• Insulin Glulisine Cartridges Consumer Information (Wolters Kluwer)
• Insulin Glulisine Pens Consumer Information (Wolters Kluwer)
• Insulin Glulisine Vials Consumer Information (Wolters Kluwer)
• Insulin glulisine Consumer Information (Cerner Multum)
• Insulin glulisine Subcutaneous Advanced Consumer Information (Micromedex)
• Insulin Glulisine AHFS DI Monographs (ASHP)

Parol

Parol may be available in the countries listed below.

Ingredient matches for Parol

Paracetamol

Paracetamol is reported as an ingredient of Parol in the following countries:

• Turkey

International Drug Name Search

Striant

Pronunciation: tes-TOS-ter-ohn
Generic Name: Testosterone
Brand Name: Striant

Striant is used for:

Treating symptoms of low testosterone in adult men when their bodies do not make any testosterone or not enough testosterone (hypogonadism). It may be used for other conditions as determined by your doctor.

Striant is a male sex hormone. It works by replacing or supplementing the testosterone that is naturally made in the body.

Do NOT use Striant if:

• you are allergic to any ingredient in Striant


• you are female


• you are pregnant or breast-feeding


• you have breast cancer or known or suspected prostate cancer

Contact your doctor or health care provider right away if any of these apply to you.

Before using Striant:

Some medical conditions may interact with Striant. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have heart disease, heart failure, coronary artery disease, angina (chest pain), high cholesterol levels, swelling (edema), lung disease, or sleep apnea (long pauses in breathing while you sleep)


• if you have diabetes, an enlarged prostate, kidney or liver disease, high blood calcium levels, or obesity

Some MEDICINES MAY INTERACT with Striant. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Carbamazepine or macrolide immunosuppressants (eg, tacrolimus) because their actions and the risk of their side effects may be increased by Striant


• Oral anticoagulants (eg, warfarin) because side effects, including risk of bleeding, may be increased by Striant

This may not be a complete list of all interactions that may occur. Ask your health care provider if Striant may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Striant:

Use Striant as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Striant comes with an additional patient leaflet. Read it carefully. Reread it each time you get Striant refilled.


• Do not remove the medicine from the blister until you are ready to take Striant. Make sure that your hands are dry when you open Striant. Use the medicine immediately after opening the blister pack. Do not store the removed tablet for future use.


• Use Striant twice a day, once in the morning and once in the evening (about 12 hours apart) unless otherwise instructed by your health care provider. You may find it convenient to apply the morning dose after brushing your teeth following breakfast and the evening dose following your evening meal.


• Do not chew or swallow the system.


• Tear off an individual unit and peel off the paper backing. Push the system through foil from the front.


• Place the flat side of the system on your fingertip. Gently push the curved side of the system just above the incisor tooth (on either side of the mouth). Each time you apply a new system, apply it to the opposite side of your mouth.


• Hold the system firmly in place with a finger on the outside of your upper lip for 30 seconds to make sure it sticks. The system is designed to stay in place until it is removed.


• If the system sticks to your cheek and not your gum, there is no need to replace the system.


• Do not remove the system until it is time for the next dose.


• To remove the system, gently slide it downward from the gum towards the tooth to avoid scratching the gum.


• Check to see if the system is in place after brushing your teeth, using mouthwash, eating food, or drinking beverages. If the system does not stick or falls off, follow the directions below.


• If the system does not stick or falls off within the first 8 hours, remove the original system and apply a new one. Apply the next system about 12 hours after the original system that you applied first.


• If the system falls off after 8 hours but before 12 hours, replace the original system. This replacement will serve as the second dose for the day.


• After removing the used medicine, discard the system out of reach of children and pets.


• If you miss a dose of Striant, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Striant.

Important safety information:

• Regularly inspect your gums where you apply the system. Gum side effects (redness, irritation, swelling, or pain) are usually temporary. Most only last for a few days, but some may last up to 2 weeks. Contact your health care provider at once if you have any unusual side effects.


• Tell your doctor or dentist that you take Striant before you receive any medical or dental care, emergency care, or surgery.


• Additional monitoring of your dose or condition may be needed if you are taking corticosteroids (eg, prednisone), insulin, oral diabetic medicines (eg, glyburide, metformin), or oxyphenbutazone.


• Diabetes patients - Striant may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.


• Striant may interfere with certain lab tests. Be sure your doctor and lab personnel know you are using Striant.


• Lab tests, including liver function, blood counts, blood cholesterol, prostatic specific antigen, and blood testosterone, may be performed while you use Striant. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Striant with caution in the ELDERLY; they may be more sensitive to its effects, especially an enlarged prostate or prostate cancer.


• Striant should not be used in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Using Striant while pregnant may cause harm to the fetus. It is not known if Striant is found in breast milk. Striant should not be used by women.

Possible side effects of Striant:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Acne; bitter or strange taste in mouth; change in sex drive; fatigue; gum or mouth irritation; gum pain; gum tenderness or swelling; hair loss; headache.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); breast growth or pain; change in the size or shape of the testicles; dark urine or light-colored bowel movements; depression or mood changes; dizziness; gingivitis; interrupted breathing while sleeping; loss of appetite; nausea; painful or prolonged erection; stomach pain; swelling of the ankles or legs; urination problems; weight gain; yellowing of the skin or eyes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Striant side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include confusion; one-sided weakness; vision problems.

Proper storage of Striant:

Store Striant at room temperature, between 68 and 77 degrees F (20 and 25 degrees C), away from heat, moisture, and light. Do not store in the bathroom. Do not use a damaged blister package. Throw Striant away in a household trash can in a way that prevents children or pets from accidentally using or taking them.

Keep Striant out of the reach of children and away from pets.

General information:

• If you have any questions about Striant, please talk with your doctor, pharmacist, or other health care provider.


• Striant is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Striant. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Striant resources

• Striant Side Effects (in more detail)
• Striant Use in Pregnancy & Breastfeeding
• Drug Images
• Striant Drug Interactions
• Striant Support Group
• 0 Reviews for Striant - Add your own review/rating

• Striant Advanced Consumer (Micromedex) - Includes Dosage Information


• Striant Prescribing Information (FDA)


• Striant Consumer Overview


• Testosterone Professional Patient Advice (Wolters Kluwer)


• Testosterone Monograph (AHFS DI)


• Testosterone Prescribing Information (FDA)


• AndroGel Prescribing Information (FDA)


• Androderm Prescribing Information (FDA)


• Androderm Advanced Consumer (Micromedex) - Includes Dosage Information


• Androgel Advanced Consumer (Micromedex) - Includes Dosage Information


• Androgel Consumer Overview


• Axiron Prescribing Information (FDA)


• Axiron Consumer Overview


• Delatestryl Prescribing Information (FDA)


• Depo-Testosterone Prescribing Information (FDA)


• Fortesta Consumer Overview


• Testim Prescribing Information (FDA)


• Testosterone Cypionate Prescribing Information (FDA)


• Testosterone Enanthate Prescribing Information (FDA)

Compare Striant with other medications

• Hypogonadism, Male